ClariVest Asset Management’s Aldeyra Therapeutics ALDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-130,044
| Closed | -$869K | – | 873 |
|
|
2023
Q3 | $869K | Hold |
130,044
| – | – | 0.05% | 260 |
|
|
2023
Q2 | $1.09M | Buy |
130,044
+23,588
| +22% | +$198K | 0.05% | 234 |
|
|
2023
Q1 | $1.06M | Buy |
106,456
+56
| +0.1% | +$556 | 0.05% | 279 |
|
|
2022
Q4 | $741K | Sell |
106,400
-1,600
| -1% | -$11.1K | 0.04% | 324 |
|
|
2022
Q3 | $577K | Hold |
108,000
| – | – | 0.03% | 348 |
|
|
2022
Q2 | $431K | Hold |
108,000
| – | – | 0.02% | 396 |
|
|
2022
Q1 | $480K | Sell |
108,000
-15,200
| -12% | -$67.6K | 0.02% | 392 |
|
|
2021
Q4 | $493K | Buy |
123,200
+56,100
| +84% | +$224K | 0.02% | 434 |
|
|
2021
Q3 | $590K | Sell |
67,100
-600
| -0.9% | -$5.28K | 0.02% | 416 |
|
|
2021
Q2 | $767K | Buy |
+67,700
| New | +$767K | 0.03% | 349 |
|